Hikal Q1 Results
- BSE: 524735
- NSE: HIKAL
- ISIN: INE475B01022
- Sector: Biotechnology & Drugs
BSE
369
-4.65 (-1.24%)
-4.65 (-1.24%)Volume13.11 K
Updated: Fri 17 Jan, 2025 | 15:29:55
NSE
369.2-4.35 (-1.16%)
-4.35 (-1.16%)Volume1.03 L
Updated: Fri 17 Jan, 2025 | 15:56:30
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Hikal Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 24 | Mar 24 | QoQ Comp | Jun 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 406.80 | 514.10 | -20.87% | 388.05 | 4.83% |
| Selling/ General/ Admin Expenses Total | 57.10 | 63.78 | -10.47% | 59.63 | -4.24% |
| Depreciation/ Amortization | 31.80 | 32.34 | -1.67% | 27.73 | 14.68% |
| Other Operating Expenses Total | 99.40 | 121.61 | -18.26% | 107.66 | -7.67% |
| Total Operating Expense | 380.60 | 451.98 | -15.79% | 365.49 | 4.13% |
| Operating Income | 26.20 | 62.12 | -57.82% | 22.56 | 16.13% |
| Net Income Before Taxes | 6.90 | 47.33 | -85.42% | 9.71 | -28.94% |
| Net Income | 5.10 | 33.97 | -84.99% | 6.92 | -26.30% |
| Diluted Normalized EPS | 0.41 | 2.75 | -85.11% | 0.56 | -26.79% |